The team from A*STAR's BTI and IMBC, EDDC, NCCS and NCIS involved in the development of EBC-129 and the test to be used for patient selection, as well as the clinical trial for EBC-129 (IMAGE)

Agency for Science, Technology and Research (A*STAR), Singapore

The team from A*STAR's BTI and IMBC, EDDC, NCCS and NCIS involved in the development of EBC-129 and the test to be used for patient selection, as well as the clinical trial for EBC-129

Caption

Left to Right: Dr Matthew NG (NCCS), Mr NEO Zhen Wei (IMCB), Dr Daniel TAN (NCCS), Dr Joe YEONG (IMCB), Dr Gopal IYER (NCCS), Dr YONG Wei Peng (NCIS), Dr Simone DORFMUELLER (EDDC), Dr Veronica DIERMAYR (EDDC), Mr Jeffrey LIM (IMCB), Ms LEE Yock Ann (EDDC), Dr Venkateshan SRIRANGAM (EDDC), Dr LEUNG Hau Wan (BTI), Dr Andre CHOO (BTI), Ms GOH Ting Hwee (BTI)

Credit

A*STAR, EDDC

Usage Restrictions

Image may only be used with appropriate credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.